2m 2m 2m 2m 2m 2m 2m
LB PHARM (LBRX)
NASDAQ
$47.72+$0.10 (+0.21%)
Price as of Aug 21, 2026 7:30 PM EDT- $1.5BMarket Cap
- N/A1-Year Change
- BiotechnologyIndustry
LB PHARM (LBRX)
$47.72+$0.10 (+0.21%)
LBRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $47.62 | ||
Change | +$0.39 (+0.83%) | ||
Open | $47.71 | ||
High | $48.21 | ||
Low | $46.34 | ||
Previous Close | $47.23 | ||
Volume | 225,827 | ||
30-Day Average Volume | 409,406 | ||
1-Week Change | -0.32% | ||
1-Month Change | 47.38% | ||
1-Year Change | N/A | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 32.3M | ||
Total Assets | $361.7M | ||
Market Cap | $1.5B | ||
Enterprise Value | $1.3B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$51.6M | ||
Free Cash Flow | -$38.0M | ||
EBIT | -$51.6M | ||
EBITDA | -$51.5M | ||
Net Working Capital | $331.7M | ||
EPS | -$1.71 | ||
Enterprise Value/EBITDA | -24 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 5 | ||
P/E | -28 | ||
PEG | 0 | ||
Price/Free Cash Flow | -40 | ||
Price/Operating Cash Flow | -41 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue